Everest Medicines Announces NMPA Full Approval of NEFECON, Broadening Treatment Access for IgA Nephropathy Patients in China
HONG KONG, May 7, 2025 - (ACN Newswire) - Everest Medicines (HKEX: 1952.HK) today announced that the supplemental New Drug Application